HPV

Hybribio Calls for Raising International HPV Awareness

Retrieved on: 
星期一, 三月 4, 2024
International, Hospital, Cervical cancer, Woman, IPVS, SOX1, Methylation, Cancer, Human papillomavirus infection, Wart, Vaccination, World Health Organization, Fluorescence, Organization, HPV, Vagina, WHO, PCR, NMPA

On this special day, Hybribio (300639.SZ) calls for raising international HPV awareness and adopting effective strategies for early detection and prevention.

Key Points: 
  • On this special day, Hybribio (300639.SZ) calls for raising international HPV awareness and adopting effective strategies for early detection and prevention.
  • In this case, raising HPV awareness, getting timely vaccination and high-quality screening together contribute significantly to the prevention of HPV infection and related diseases.
  • Hybribio has developed a complete HPV molecular diagnostic solution covering 14 High-risk HPV GenoArray Diagnostic Kit, 14 High-risk HPV with 16/18 Genotyping Real-time PCR Kit, 14 High-risk HPV E6/E7 mRNA Real-time PCR Kit (PCR with Fluorescent Probe), 21 HPV GenoArray Diagnostic Kit, 37 HPV GenoArray Diagnostic Kit, 13 High-risk HPV Real-time PCR Kit, 23 HPV Genotyping Real-time PCR Kit, SOX1 and PAX1 Methylation Real-time PCR Kit.
  • Raising international HPV awareness is the very first step against cervical cancer.

Hybribio Calls for Raising International HPV Awareness

Retrieved on: 
星期一, 三月 4, 2024
International, Hospital, Cervical cancer, Woman, IPVS, SOX1, Methylation, Cancer, Human papillomavirus infection, Wart, Vaccination, World Health Organization, Fluorescence, Organization, HPV, Vagina, WHO, PCR, NMPA

On this special day, Hybribio (300639.SZ) calls for raising international HPV awareness and adopting effective strategies for early detection and prevention.

Key Points: 
  • On this special day, Hybribio (300639.SZ) calls for raising international HPV awareness and adopting effective strategies for early detection and prevention.
  • In this case, raising HPV awareness, getting timely vaccination and high-quality screening together contribute significantly to the prevention of HPV infection and related diseases.
  • Hybribio has developed a complete HPV molecular diagnostic solution covering 14 High-risk HPV GenoArray Diagnostic Kit, 14 High-risk HPV with 16/18 Genotyping Real-time PCR Kit, 14 High-risk HPV E6/E7 mRNA Real-time PCR Kit (PCR with Fluorescent Probe), 21 HPV GenoArray Diagnostic Kit, 37 HPV GenoArray Diagnostic Kit, 13 High-risk HPV Real-time PCR Kit, 23 HPV Genotyping Real-time PCR Kit, SOX1 and PAX1 Methylation Real-time PCR Kit.
  • Raising international HPV awareness is the very first step against cervical cancer.

Procare Health: Silencing HPV infection may exacerbate the physiological effects of the emotional burden

Retrieved on: 
星期一, 三月 4, 2024
Express, International, Anxiety, Woman, Emotion, Habit, Guilt, Health, Fear, Patient, HPV, Diagnosis, Observational study, Cancer, Research, Nursing

Recognizing the importance of addressing these emotions alongside physical symptoms, Procare Health organized the third 'HPV TALKS' session on the International HPV Awareness Day.

Key Points: 
  • Recognizing the importance of addressing these emotions alongside physical symptoms, Procare Health organized the third 'HPV TALKS' session on the International HPV Awareness Day.
  • Led by Dr. Raquel Tulleuda , a gynaecologist, and Ms. Vanesa Falcón , a psychologist, the session emphasized the holistic approach needed to manage HPV, focusing on emotional well-being alongside medical treatment.
  • Clinical trials involving over 600 patients demonstrated Papilocare® vaginal gel's efficacy in normalizing cervical lesions and clearing high-risk HPV strains.
  • To address the emotional aspect of HPV management, the experts provided six key habits for patients:
    Communicate openly about the diagnosis.

HPV's Hidden Hand: New Study by Pusan National University Scientists Reveals Key Details in Head and Neck Cancer Microenvironment

Retrieved on: 
星期三, 二月 28, 2024
School, Neoplasm, Incidence, PKM2, Viral, Virology, Informatics, Assistant, Throat, Growth, Health informatics, Human papillomavirus infection, Branches of microbiology, Mouth, RNA, PKM, Tumor microenvironment, B cell, Ephrin, Patient, Glomus tumor, Journal, Tobacco, Medicine, Pusan National University, HPV, HNSCC, Head, Research, Nose, Cancer, EPHA2, Vaccine

BUSAN, South Korea, Feb. 28, 2024 /PRNewswire/ -- Head and neck squamous cell carcinoma (HNSCC) is a type of cancer that affects the mucous membranes of the mouth, nose, and throat. HNSCC is typically associated with tobacco exposure, alcohol abuse, and viral infections. The links between human papillomavirus (HPV) infection status and the molecular characteristics of HNSCC are not clearly defined.

Key Points: 
  • BUSAN, South Korea, Feb. 28, 2024 /PRNewswire/ -- Head and neck squamous cell carcinoma (HNSCC) is a type of cancer that affects the mucous membranes of the mouth, nose, and throat.
  • The links between human papillomavirus (HPV) infection status and the molecular characteristics of HNSCC are not clearly defined.
  • Therefore, the HPV infection could be considered a criterion for developing treatment strategies, thereby enabling precision medicine tailored to the patient's condition!
  • Title of original paper: Deciphering Head and Neck Cancer Microenvironment: Single–Cell and Spatial Transcriptomics Reveals Human Papillomavirus–Associated Differences

Photocure Partner Asieris to present First-ever Results of the international multicenter Phase III clinical Study for Cevira, a non-surgical treatment for cervical HSIL, at the 2024 EUROGIN

Retrieved on: 
星期四, 二月 22, 2024
Cevira, Bladder cancer, Congress, HPV, HSIL, Photocure, Mortality, Pharmaceutical industry

Read Asieris' full media release here: https://asieris.com/asieris-to-unveil-first-ever-results-of-the-internat...

Key Points: 
  • Read Asieris' full media release here: https://asieris.com/asieris-to-unveil-first-ever-results-of-the-internat...
    Cevira is a breakthrough photodynamic drug-device combination product that is being developed for non-surgical treatment of high-grade precancerous lesions of the cervix.
  • Photocure developed Cevira through Phase 1 and Phase 2 trials, and the global rights for development and commercialization were out-licensed to Asieris Meditech Co., Ltd in 2019.
  • Asieris is a global biopharma company specializing in discovering, developing and commercializing innovative drugs for the treatment of genitourinary tumors and other related diseases.
  • All trademarks mentioned in this release are protected by law and are registered trademarks of Photocure ASA.

BD Partners with Camtech Health to Increase Access to Cervical Cancer Screening in Singapore

Retrieved on: 
星期三, 二月 21, 2024
Gynaecology, Audiolab, Cervical cancer, Woman, Embarrassment, Commonwealth, FDA, Cancer, Health, IOS, Human papillomavirus infection, Death, Risk, Medicine, Vaccination, Obstetrics, World Health Organization, Fear, BDX, Android, Virus, Public, Privacy, HPV, Adviser, WHO, Elimination, Partnership, Birth control

SINGAPORE, Feb. 21, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a strategic partnership with Camtech Health, a digital health company focused on at-home health testing, to advance cervical cancer screening by offering the first-ever option for women in Singapore to self-collect a sample in the privacy of their own home.

Key Points: 
  • The program objective is to improve the rate of cervical cancer screening in Singapore, where less than half of eligible women are currently being tested.
  • "Cervical cancer is preventable, precancer is curable, and programs like this help to support the national goal of cervical cancer elimination.
  • In late 2020, the World Health Organization (WHO) launched its Global Strategy to Accelerate the Elimination of Cervical Cancer, recognizing the potential to virtually eliminate cervical cancer as a public health threat, recognizing the potential to eliminate cervical cancer in our lifetimeiii.
  • At-home collection can help address the urgent public health challenge of reaching women who do not attend routine cervical cancer screening.

Los Angeles Mayor Karen Bass Honors Dr. Siavash Arani for Healthcare Innovations

Retrieved on: 
星期六, 二月 17, 2024
Medicine, Vaccination, Health, HPV, Infection, LOS, Health care, Hope, Multimedia, Patient, Public, Medical device

LOS ANGELES, Feb. 16, 2024 /PRNewswire-PRWeb/ -- Dr. Arani, a distinguished physician known for his visionary approach in the field of medicine, especially in the treatment and management of HPV was recognized by Mayor Karen Bass, alongside council members from all 15 districts in a ceremony held at the Los Angeles City Hall.

Key Points: 
  • Presented by Los Angeles 3rd District Councilmember Bob Blumenfied, Dr. Arani is awarded for his outstanding service and dedication to improving patient care in Los Angeles.
  • Dr. Arani stands for us as a shining example of excellence in the field of health care.
  • Dr. Arani then shared his gratitude, "I am deeply honored to receive recognition from Mayor Karen Bass and the city of Los Angeles.
  • Mayor Karen Bass comments on his contributions, "He has developed strategies to treat patients with HPV-related tumors.

Cervical Cancer Studies Outline Innovative Treatment Options For Patients In 2024

Retrieved on: 
星期四, 二月 15, 2024
Cervical cancer, Research, IIB, Disability, Chemoradiotherapy, CCRT, Social, Vaccination, Risk, Survival rate, Social Security, DFS, SSDI, Patient, Social Security Disability Insurance, Survival, Disease, HPV, Ageing, Cancer, Birth control

Research highlights the critical link between HPV (human papillomavirus) and cervical cancer, with the virus responsible for the majority of cases.

Key Points: 
  • Research highlights the critical link between HPV (human papillomavirus) and cervical cancer, with the virus responsible for the majority of cases.
  • Regular cervical cancer screening is essential for those aged 21 to 65, incorporating HPV testing followed by further assessments for those with positive results.
  • In evaluating treatment efficacy for stage IB2 to IIB cervical carcinoma, a 12-year study involving 626 patients compared neoadjuvant chemotherapy followed by surgery (NACT-S) with concomitant chemoradiotherapy (CCRT).
  • Cervical Cancer Awareness Month is a crucial time to raise public awareness about cervical cancer and the importance of early detection and treatment.

Global Vaccine Technologies Market Report 2024, Featuring Abbott, Astrazeneca, Bavarian Nordic, Emergent Biosolutions, GSK, Merck, Mitsubishi Tanabe Pharma, Panacea Biotec, Pfizer & Sanofi - ResearchAndMarkets.com

Retrieved on: 
星期一, 二月 12, 2024
Biotechnology, Infectious Diseases, Health, Pharmaceutical, Clinical Trials, Acquisition, Attenuated vaccine, Immunization, BCG, Physician, Cancer, Influenza, ESG, Government, Allergy, Vaccine, Rotavirus, MMR, Disease, HPV, Infection, Diphtheria, Hepatitis, Research, Human, Pharmaceutical industry

Continuous improvements in vaccine design, delivery technologies and manufacturing will also boost market growth.

Key Points: 
  • Continuous improvements in vaccine design, delivery technologies and manufacturing will also boost market growth.
  • The global vaccine technologies market is segmented in this report by technology, disease, age, and region.
  • It discusses the market determinants, which act as motivating or restraining factors and provides insights to stakeholders and potential entrants.
  • This study looks at research and development (R&D) spending, increasing competition and new technologies, which are giving direction to the market.

Urology Care Foundation Spreads Awareness for National Cancer Prevention Month

Retrieved on: 
星期三, 一月 31, 2024
Education, Ache, Penile cancer, Urethral cancer, Urination, Kidney cancer, Bleeding, Fluid mechanics, Testicular cancer, Heredity, Urethra, Radiation, Back pain, Infection, Bladder cancer, Abdomen, Foreskin, Weight loss, FACS, Fever, Groin, Risk factor, Diet, AUA, Blog, Cancer, HPV, Combustion, Woman, Urethral caruncle, Growth, Papillomaviridae, Prostate cancer, Low back pain, Penis, Urethral diverticulum, Rib, Death, Skin, Blood, Disease, AIDS, Risk, Ejaculation, Smoking, Workplace, UTI, American Urological Association, Male, Scrotum, Pain, Tenderness, MBA, Somatic symptom disorder, Urine, Smoker, GCNIS, Ulcer, Birth control

BALTIMORE, Jan. 31, 2024 (GLOBE NEWSWIRE) -- February is National Cancer Prevention Month, and the Urology Care Foundation, the official foundation of the American Urological Association (AUA), wants to spread awareness and information on the six main urologic cancers.

Key Points: 
  • BALTIMORE, Jan. 31, 2024 (GLOBE NEWSWIRE) -- February is National Cancer Prevention Month, and the Urology Care Foundation, the official foundation of the American Urological Association (AUA), wants to spread awareness and information on the six main urologic cancers.
  • However, there are other urologic cancers that involve the bladder, kidneys and testicles,” said Urology Care Foundation Board of Directors member Brian McNeil, MD, MBA, FACS.
  • The Urology Care Foundation believes the first part of prevention is education.
  • Below are the six main urologic cancers and important resources for each:
    Bladder Cancer is the second most common type of urologic cancer.